Chemoresistance is a multifactorial phenomenon that contributes to the failure of chemotherapies and dismal survival rates in patients with pancreatic cancer.42 Wey et al41 demonstrated the role of NRP‐1 overexpression in mediating chemotherapy resistance in PDAC. This evidence concerns the gene NRP1 and pancreatic neoplasm.